{ "docId": "019dd923-5fec-763b-95d0-6c2b37f81466", "docSlug": "bi-9523b367be63361f", "documentTitle": "3T Biosciences 27-slide pitch deck to raise $40M Series A", "authorId": "Pitchdecks", "authorName": "3T Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.6, "pageNumber": 6, "pageCount": 27, "prevPage": 5, "nextPage": 7, "slideType": "team_bio", "function": "other", "density": "overcrowded", "nDataPoints": 0, "notes": null, "elementsJson": [ "headline_text", "action_title", "headshot", "bullet_list" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-5fec-763b-95d0-6c2b37f81466/6", "deckHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466", "deckJsonHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466.json", "deckAnchorHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466#slide-6", "components": [ { "bbox": { "h": 0.183, "w": 0.145, "x": 0.05, "y": 0.438 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "143f4552-052e-4769-9ef3-13637fdf8a37", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.183, "w": 0.145, "x": 0.528, "y": 0.438 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "38c1147a-9637-41ff-b6a1-0c2dac9d0959", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.183, "w": 0.145, "x": 0.528, "y": 0.215 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "40e9dc6d-3301-416f-b7bf-bc6f01d84091", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.183, "w": 0.145, "x": 0.05, "y": 0.67 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "b8c2dee3-3c22-44e3-8ca9-e557e08e1399", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.183, "w": 0.145, "x": 0.05, "y": 0.233 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "f1168d04-46cd-4bef-808a-d16e6579374f", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.15, "w": 0.3, "x": 0.16, "y": 0.215 }, "kind": "paragraph", "text": "Stefan Scherer, MD, PhD\nChief Executive Officer and Board Member\n- 20+ years of industry experience (Roche/Genentech, Novartis, Cellectis, GSK)\n- Cell-therapy expert (CMO and SVP Clinical Development at Cellectis, VP & Head Early Development, Strategy Innovation at Novartis)\n- Biomarker expert (Global Biomarker Head at Genentech)", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "2fd715db-abfa-46bf-a916-04ae74a637c4", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.2, "w": 0.3, "x": 0.16, "y": 0.665 }, "kind": "paragraph", "text": "Venita DeAlmeida, PhD\nVP Program Development\n- 18 years of industry experience in development of ADCs, Bispecifics and other biologics\n- Genentech, Sutro Biopharma,\n- Oversaw multiple bispecific and ADC programs advancing to IND/Phase 1\n- Developed preclinical and clinical strategy for early phase drug development of clinical candidates\n- Responsible for internal and regulatory documents, KOL interactions, companion diagnostics, biomarker strategy", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "69fed8fc-3a8c-4bc5-9ced-23733e82d0ef", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.2, "w": 0.3, "x": 0.64, "y": 0.43 }, "kind": "paragraph", "text": "Leah Sibener, PhD\nVP Therapeutic Discovery, Co-Founder\n- Inventor of Core 3T Technology\n- 13+ years of research experience, Stanford PhD Immunology\n- Led cross functional team elucidating the mechanism of optimal T cell receptor signaling (Cell)\n- Previous experience at Genentech, Johns Hopkins (Jonathan Schneck Lab)\n- Multiple High-Impact Publications Related to 3T Technology (Cell, Nature Genetics, Nature Immunology, eLife, PNAS, Trends in Cancer, Biochemical Pharmacology)", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "763c16a0-08d6-4402-a80a-b72a1bddc765", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.2, "w": 0.3, "x": 0.16, "y": 0.43 }, "kind": "paragraph", "text": "Marvin Gee, PhD\nVP Target Discovery, Co-Founder\n- Inventor of Core 3T Technology\n- 13+ years of research experience, Stanford PhD Immunology\n- Computational Systems Immunology Focus at Stanford University\n- Led POC study using 3T Technology for TCR de-orphanization\n- Previous experience at National Cancer Institute, Caltech (David Baltimore Lab)\n- Multiple High-Impact Publications Related to 3T Technology (Cell, Nature, Nature Immunology, Nature Chemical Biology, PNAS, Trends in Cancer, Biochemical Pharmacology)", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "7c957260-bf01-4f17-b5fb-ff7d4fb61c7d", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.15, "w": 0.3, "x": 0.64, "y": 0.215 }, "kind": "paragraph", "text": "Christopher DeRespino, MBA\nChief Business Officer\n- 15+ years of industry experience\n- Previous leadership roles in business development at Amgen, Onyx, Pfizer & Adverum (CBO/Acting CFO)\n- Extensive track record completing transactions of various sizes from discovery to commercialization, including in-licensing, out-licensing, M&A and clinical & diagnostic collaborations", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "7ee39cc4-a00e-420f-aebd-8e945b163679", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.05, "y": 0.08 }, "kind": "title", "text": "3T's Experienced Leadership Team Is Led by Industry Veterans", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "d93dac93-768d-437f-b744-655ea5a7a53e", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }